subscribeSubscribe
Biocon leads India`s push into anti-obesity drugs as patents lapse

Biocon leads India`s push into anti-obesity drugs as patents lapse
BUSINESS STANDARD
08 Apr 2024
Share Share
Biocon to obtain approval for diabetes drug, Liraglutide in UK

Biocon to obtain approval for diabetes drug, Liraglutide in UK
INDINPHARMAPOST
28 Mar 2024
Share Share
UK probes GLP-1 drugs` potential suicide risks

UK probes GLP-1 drugs` potential suicide risks
Angus Liu FIERCE PHARMA
27 Jul 2023
Share Share
Weight-loss drug shortage expands to Novo`s Saxenda

Weight-loss drug shortage expands to Novo`s Saxenda
Angus Liu FIERCE PHARMA
20 Jul 2023
Share Share
EU extends Ozempic review to include more weight-loss, diabetes drugs

EU extends Ozempic review to include more weight-loss, diabetes drugs
REUTERS
13 Jul 2023
Share Share
EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts

EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts
REUTERS
11 Jul 2023
Share Share
Novo`s Biologic Xultophy (Degludec, Liraglutide) Receives Approval in the U.S.

Novo`s Biologic Xultophy (Degludec, Liraglutide) Receives Approval in the U.S.
FDA
10 Jul 2023
Share Share
Sciwind to Highlight Positive Data for GLP-1 Peptide Agonist Ecnoglutide

Sciwind to Highlight Positive Data for GLP-1 Peptide Agonist Ecnoglutide
PR NEWSWIRE
23 Jun 2023
Share Share
Novo Nordisk`s Wegovy woes were an unexpected boon for Saxenda

Novo Nordisk`s Wegovy woes were an unexpected boon for Saxenda
Fraiser Kansteiner FIERCEPHARMA
04 Aug 2022
Share Share
Risk of patient overlap between Wegovy and Saxenda obesity drugs, Novo says

Risk of patient overlap between Wegovy and Saxenda obesity drugs, Novo says
REUTERS
07 Jun 2021
Share Share